Follow The Filings

NHI National Health Investors

National Health Investors earnings company data as of 7:13 AM ET 11/17

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS 4.08 GAAP 11.47 —
Rev $112.2M $113.5M Beat +1.2%

Insider trades

Open-market buys and sales by NHI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NHI insider trades
  • $258K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. D. Eric Mendelsohn CEO
    Buy
    $91K 1,500 shares at $60.53 +1.1% to stake
    Traded Nov 17 Filed Nov 18
  2. Robert A. McCabe Jr. Director
    Buy
    $64K 890 shares at $71.65 +2.1% to stake
    Traded Jun 15 Filed Jun 15
  3. D. Eric Mendelsohn CEO
    Buy
    $103K 1,500 shares at $68.84 +1.1% to stake
    Traded Jun 5 Filed Jun 5

Also filed in the last 12 months, not counted as buying or selling: 40 option exercises, 26 share withholdings for taxes, 12 stock grants, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.02,9.01
10-Q
8-K 7.01,9.01
8-K 2.02,9.01
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 5.02,9.01
10-Q
8-K 2.02,9.01
8-K 7.01,9.01
8-K 7.01,9.01
SCHEDULE 13G —
8-K 5.02,9.01
SCHEDULE 13G/A —
8-K 5.02
8-K 1.02,2.01
8-K 8.01
8-K 5.07
10-Q
8-K 2.02,9.01
8-K 7.01,9.01
8-K 7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
8-K 5.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf